$4.13
Value $398M
ACTG and WELL stock compared: price, dividend, valuation and results, from SEC filings.
$4.13
Value $398M
$244.65
Value $179B
Acacia Research (ACTG) has a market value of $398M and Welltower (WELL) $179B. Over the last year, with dividends, ACTG moved +12.5% and WELL +28.0%. Dividend yield: ACTG none, WELL 1.30%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
ACTG$398M
WELL$179B
WELL is 450 times ACTG
Revenue, 12 months
ACTG$273M
WELL$13.8B
WELL is 50 times ACTG
Net income, 12 months
ACTG-$18M
WELL$1.7B
Operating margin
ACTG-6.0%
WELL–
ROIC
ACTG-2.1%
WELL–
P/E
ACTG–
WELL107.7
Dividend yield
ACTG0.0%
WELL1.3%
1.3 points apart
5-year return
ACTG-25.2%
WELL+226.1%
251.3 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
ACTG-25.2%
WELL+226.1%
| Period | ACTGWith dividends | WELLWith dividends |
|---|---|---|
| 1 year since November 14, 2025 | +12.5%Price +12.5% | +28.0%Price +26.2% |
| 3 years since November 16, 2023 | +11.3%+3.6% a yearPrice +11.3% | +197.8%+43.9% a yearPrice +182.0% |
| 5 years since November 15, 2021 | -25.2%-5.6% a yearPrice -25.2% | +226.1%+26.7% a yearPrice +190.5% |
| 10 years since November 16, 2016 | -35.5%-4.3% a yearPrice -35.5% | +446.5%+18.5% a yearPrice +288.3% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
ACTGAcacia ResearchWELLWelltower
| Price | $4.13 | $244.65 |
|---|---|---|
| Market value | $398M | $179B |
| Enterprise value (EV) | $169M | – |
| P/E | – | 107.7 |
| P/E, 5-year median | 6.8 | – |
| P/B | 0.8 | 3.7 |
| EV/EBIT | – | – |
| Free cash flow yield | – | 1.2% |
| Revenue, 12 months | $273M | $13.8B |
|---|---|---|
| Net income, 12 months | -$18M | $1.7B |
| Free cash flow, 12 months | – | $2.1B |
| Earnings per share, 12 months | -$0.19 | $2.30 |
| Revenue growth, year on year | 133.2% | 35.6% |
| Revenue growth a year, past | +57.1%over 5 years | +18.7%over 5 years |
| EPS growth a year, past | -31.7%over 5 years | -9.8%over 5 years |
| Gross margin | 23.2% | 39.2% |
|---|---|---|
| Operating margin | -6.0% | – |
| Net margin | -6.5% | 12.1% |
| ROIC | -2.1% | – |
| ROE | -3.4% | 3.8% |
| Cash | $337M | $2.3B |
|---|---|---|
| Total debt | $119M | $20.1B |
| Net debt / EBITDA | -8.5 | – |
| Interest cover | -2.2× | – |
| Dividend yield | – | 1.3% |
|---|---|---|
| Dividend per share, 12 months | – | $3.18 |
| Dividend growth a year, past | – | +0.9%over 5 years |
| Buyback yield | – | – |
| Shareholder yield | – | 1.3% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Welltower ($179B) is about 450.4 times Acacia Research ($398M), at today's prices.
Since November 16, 2016, ACTG's price moved -35.5% and WELL's +288.3%. With dividends: ACTG -35.5% (-4.3% a year), WELL +446.5% (+18.5% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for Acacia Research and 1.30% for Welltower. Over the last twelve months they paid – and $3.18 per share.
Over the last twelve months, the net margin was -6.5% for Acacia Research and 12.1% for Welltower, and the operating margin -6.0% and –. Revenue was $273M and $13.8B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.